Vivus LLC, 2024, "Highlights of prescribing information" PH-03-002-16, Revised: 09/2024
GHK-Cu 50MG is also commonly referenced in laboratory studies involving cutaneous, scalp, and hair-follicle cellular models used for skin and hair analysis, including fibroblasts, blood-flow-related signaling, production signals for hair follicles, matrix markers, regeneration markers, and experimental growth-phase activity, and may be evaluated alongside other peptides or GHK-Cucontaining peptide blends such as GLOW 70MG
Magkos, F
#MindMattersPsychiatryWeightLoss #Psychiatry #HealthyLiving To view or add a comment, sign in It's a great study further emphasising our need to move away from."eat less, move more" as a management strategy in antipsychotic associated weight gain
K.MaherP